Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Read more about Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Read more about Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study.
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients. Read more about Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML. Read more about A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation. Read more about Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease. Read more about A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis. Read more about Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.
Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL. Read more about Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL.
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS. Read more about Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies. Read more about Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies.
